After Pfizer, SII too seeks indemnity

Tribune Web Desk

Updated At : 12:49 PM Jun 04, 2021 IST

Unlock Exclusive Insights with The Tribune Premium

Take your experience further with Premium access. Thought-provoking Opinions, Expert Analysis, In-depth Insights and other Member Only Benefits

Yearly Premium ₹999 ₹349/Year

Yearly Premium $49 $24.99/Year

New Delhi, June 3

The Serum Institute of India that produces Covishield on Thursday sought indemnity from liability from the government, hoping that same rules will apply to both foreign and Indian-made vaccines.

Led by Adar Poonawalla, the SII is learnt to have told the government that legal protections for all vaccine makers —Indian and foreign — should be the same and no distinction should be made. The SII’s request follows government’s inclination to grant indemnity to US-made Pfizer and Moderna vaccines. — TNS

The Tribune, now published from Chandigarh, started publication on February 2, 1881, in Lahore (now in Pakistan). It was started by Sardar Dyal Singh Majithia, a public-spirited philanthropist, and is run by a trust comprising five eminent persons as trustees.

The Tribune, the largest selling English daily in North India, publishes news and views without any bias or prejudice of any kind. Restraint and moderation, rather than agitational language and partisanship, are the hallmarks of the newspaper. It is an independent newspaper in the real sense of the term.

The Tribune has two sister publications, Punjabi Tribune (in Punjabi) and Dainik Tribune (in Hindi).

Remembering Sardar Dyal Singh Majithia

Designed and developed by : SORTD

Unlock Exclusive Insights with The Tribune Premium

Suggested Articles